MARCKS and lung cancer: Through treatment with 50 μM MPS peptide in lung cancer cells exposed to 20% CSE, we confirmed that MPS peptide had an inhibitory effect on smoke-enhanced MARCKS phosphorylation in both CL1-0 and H292 cells (Figure 5C).